TGen Study Suggests Potential for RNAi Screening in Developing Combo Treatments for Cancer

In the study, researchers demonstrated "the effectiveness of high-throughput RNAi screening as a tool for identifying sensitizing targets to known and established chemotherapeutic agents."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.